These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 31171722)

  • 21. Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
    Lappano R; Maggiolini M
    Drugs; 2017 Jun; 77(9):951-965. PubMed ID: 28401445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
    Sriram K; Insel PA
    Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances of Small Molecular Regulators Targeting G Protein- Coupled Receptors Family for Oncology Immunotherapy.
    He P; Zhou W; Liu M; Chen Y
    Curr Top Med Chem; 2019; 19(16):1464-1483. PubMed ID: 31264549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.
    Tang XL; Wang Y; Li DL; Luo J; Liu MY
    Acta Pharmacol Sin; 2012 Mar; 33(3):363-71. PubMed ID: 22367282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.
    De Francesco EM; Sotgia F; Clarke RB; Lisanti MP; Maggiolini M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29240722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and design of G protein-coupled receptor targeting antibodies.
    Peterson SM; Hutchings CJ; Hu CF; Mathur M; Salameh JW; Axelrod F; Sato AK
    Expert Opin Drug Discov; 2023 Apr; 18(4):417-428. PubMed ID: 36992620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling.
    Arakaki AKS; Pan WA; Trejo J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GPCR Modulation in Breast Cancer.
    Lappano R; Jacquot Y; Maggiolini M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation.
    Crouch MF; Osmond RI
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):344-56. PubMed ID: 18537556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural mechanism of G protein activation by G protein-coupled receptor.
    Duc NM; Kim HR; Chung KY
    Eur J Pharmacol; 2015 Sep; 763(Pt B):214-22. PubMed ID: 25981300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
    O'Hayre M; Vázquez-Prado J; Kufareva I; Stawiski EW; Handel TM; Seshagiri S; Gutkind JS
    Nat Rev Cancer; 2013 Jun; 13(6):412-24. PubMed ID: 23640210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: G Protein-coupled Receptors and RGS Proteins.
    Stewart A; Fisher RA
    Prog Mol Biol Transl Sci; 2015; 133():1-11. PubMed ID: 26123299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPCRs and cancer.
    Lappano R; Maggiolini M
    Acta Pharmacol Sin; 2012 Mar; 33(3):351-62. PubMed ID: 22266725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of prostate cancer by hormone-responsive G protein-coupled receptors.
    Wang W; Chen ZX; Guo DY; Tao YX
    Pharmacol Ther; 2018 Nov; 191():135-147. PubMed ID: 29909235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of surface plasmon resonance imaging to monitoring G protein-coupled receptor signaling and its modulation in a heterologous expression system.
    Nonobe Y; Yokoyama T; Kamikubo Y; Yoshida S; Hisajima N; Shinohara H; Shiraishi Y; Sakurai T; Tabata T
    BMC Biotechnol; 2016 Apr; 16():36. PubMed ID: 27068216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hijacking GPCRs by viral pathogens and tumor.
    Zhang J; Feng H; Xu S; Feng P
    Biochem Pharmacol; 2016 Aug; 114():69-81. PubMed ID: 27060663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.
    Li S; Huang S; Peng SB
    Int J Oncol; 2005 Nov; 27(5):1329-39. PubMed ID: 16211229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways.
    Kostenis E
    Curr Pharm Des; 2006; 12(14):1703-15. PubMed ID: 16712483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.